ArticleJournal of enzyme inhibition and medicinal chemistry2022

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer.

Dafeng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.